Rekah Pharmaceutical Industry Ltd (REKA) — Cash Flow-to-Debt Ratio
Rekah Pharmaceutical Industry Ltd (REKA) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2026, meaning its operating cash flow of ILA13.82 Million could theoretically repay 0% of its total liabilities (ILA281.29 Million) in one year. See REKA financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Rekah Pharmaceutical Industry Ltd Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for Rekah Pharmaceutical Industry Ltd across 20 annual periods. For the full cash flow conversion analysis, see REKA cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for Rekah Pharmaceutical Industry Ltd (2004–2025)
Year-by-year debt coverage analysis for Rekah Pharmaceutical Industry Ltd. Check Rekah Pharmaceutical Industry Ltd (REKA) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | ILA12.95 Million | ILA279.47 Million | ▼ -50.2% |
| 2024 | 0.09x | ILA26.54 Million | ILA285.24 Million | ▲ +8.0% |
| 2023 | 0.09x | ILA28.35 Million | ILA329.14 Million | ▼ -36.8% |
| 2022 | 0.14x | ILA39.00 Million | ILA286.34 Million | ▲ +69.9% |
| 2021 | 0.08x | ILA21.17 Million | ILA264.02 Million | ▲ +80.6% |
| 2020 | 0.04x | ILA11.28 Million | ILA254.10 Million | ▼ -72.3% |
| 2019 | 0.16x | ILA33.91 Million | ILA211.89 Million | ▲ +38.5% |
| 2018 | 0.12x | ILA17.28 Million | ILA149.62 Million | ▼ -27.0% |
| 2017 | 0.16x | ILA23.80 Million | ILA150.33 Million | ▲ +50.4% |
| 2016 | 0.11x | ILA22.82 Million | ILA216.86 Million | ▲ +262.9% |
| 2015 | 0.03x | ILA5.81 Million | ILA200.17 Million | ▲ +408.3% |
| 2014 | 0.01x | ILA1.33 Million | ILA233.05 Million | ▼ -89.1% |
| 2013 | 0.05x | ILA11.71 Million | ILA223.65 Million | ▼ -16.3% |
| 2012 | 0.06x | ILA14.18 Million | ILA226.90 Million | ▲ +108.1% |
| 2010 | 0.03x | ILA6.73 Million | ILA224.18 Million | ▼ -75.3% |
| 2009 | 0.12x | ILA26.03 Million | ILA214.25 Million | ▲ +328.6% |
| 2008 | 0.03x | ILA6.57 Million | ILA231.87 Million | ▼ -46.7% |
| 2007 | 0.05x | ILA12.45 Million | ILA233.86 Million | ▲ +159.2% |
| 2005 | 0.02x | ILA4.27 Million | ILA208.15 Million | ▼ -82.4% |
| 2004 | 0.12x | ILA17.87 Million | ILA153.18 Million | — |